BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20576822)

  • 21. Abnormal Diurnal Patterns of Parathyroid Hormone are Associated with Sustained Mild Hypercalcemia in Non-Dialyzed Chronic Kidney Disease.
    Yamato M; Takaori K; Tomiyama Y; Fujimura R; Yokobatake C; Wada A; Ito T
    Clin Lab; 2016; 62(1-2):81-8. PubMed ID: 27012036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The FGF-23/klotho axis and its relationship with phosphorus, calcium, vitamin D, PTH, aldosterone, severity of disease, and outcome in hospitalised foals.
    Kamr AM; Dembek KA; Hildreth BE; Morresey PR; Rathgeber RA; Burns TA; Zaghawa AA; Toribio RE
    Equine Vet J; 2018 Nov; 50(6):739-746. PubMed ID: 29660161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Isakova T; Cai X; Lee J; Mehta R; Zhang X; Yang W; Nessel L; Anderson AH; Lo J; Porter A; Nunes JW; Negrea L; Hamm L; Horwitz E; Chen J; Scialla JJ; de Boer IH; Leonard MB; Feldman HI; Wolf M;
    Am J Kidney Dis; 2020 Feb; 75(2):235-244. PubMed ID: 31668375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients.
    Kirkpantur A; Altun B; Hazirolan T; Akata D; Arici M; Kirazli S; Turgan C
    Artif Organs; 2009 Oct; 33(10):844-54. PubMed ID: 19681840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease.
    Harjes LM; Parker VJ; Dembek K; Young GS; Giovaninni LH; Kogika MM; Chew DJ; Toribio RE
    J Vet Intern Med; 2017 May; 31(3):784-790. PubMed ID: 28419560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of fetuin-A with glomerular filtration rate and endothelial dysfunction in moderate-severe chronic kidney disease.
    Cottone S; Palermo A; Arsena R; Riccobene R; Guarneri M; Mulè G; Tornese F; Altieri C; Vaccaro F; Previti A; Cerasola G
    J Nephrol; 2010; 23(1):62-9. PubMed ID: 20091488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetuin-A is associated with calcified coronary artery disease.
    Mori K; Ikari Y; Jono S; Emoto M; Shioi A; Koyama H; Shoji T; Ishimura E; Inaba M; Hara K; Nishizawa Y
    Coron Artery Dis; 2010 Aug; 21(5):281-5. PubMed ID: 20436350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study.
    Navarro-González JF; Mora-Fernández C; Muros M; Herrera H; García J
    Clin J Am Soc Nephrol; 2009 Oct; 4(10):1646-54. PubMed ID: 19808245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma cystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease.
    Kiyosue A; Hirata Y; Ando J; Fujita H; Morita T; Takahashi M; Nagata D; Kohro T; Imai Y; Nagai R
    Circ J; 2010 Nov; 74(11):2441-7. PubMed ID: 20921817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology.
    Ärnlöv J; Carlsson AC; Sundström J; Ingelsson E; Larsson A; Lind L; Larsson TE
    Clin J Am Soc Nephrol; 2013 May; 8(5):781-6. PubMed ID: 23335040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acid Load and Phosphorus Homeostasis in CKD.
    Khairallah P; Isakova T; Asplin J; Hamm L; Dobre M; Rahman M; Sharma K; Leonard M; Miller E; Jaar B; Brecklin C; Yang W; Wang X; Feldman H; Wolf M; Scialla JJ;
    Am J Kidney Dis; 2017 Oct; 70(4):541-550. PubMed ID: 28645705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study.
    Alshahawey M; El Borolossy R; El Wakeel L; Elsaid T; Sabri NA
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):626-633. PubMed ID: 33594986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
    Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
    Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of fibroblast growth factor 23 and fetuin-A with coronary plaque burden and plaque composition in young adults.
    Akin F; Celik O; Ayca B; Altun I; Diker VO; Bıyık I; Siriopol D; Covic A; Kanbay M
    J Investig Med; 2015 Apr; 63(4):613-9. PubMed ID: 25679296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD.
    Malhotra R; Katz R; Hoofnagle A; Bostom A; Rifkin DE; Mcbride R; Probstfield J; Block G; Ix JH
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):36-44. PubMed ID: 29208626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.
    Parker VJ; Harjes LM; Dembek K; Young GS; Chew DJ; Toribio RE
    J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.
    Levin A; Bakris GL; Molitch M; Smulders M; Tian J; Williams LA; Andress DL
    Kidney Int; 2007 Jan; 71(1):31-8. PubMed ID: 17091124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTH, FGF-23 and early CKD.
    Rodriguez M; Felsenfeld AJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3391-3. PubMed ID: 18676347
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence of CKD-MBD in pre-dialysis patients using biochemical markers in Enugu, South-East Nigeria.
    Okoye JU; Arodiwe EB; Ulasi II; Ijoma CK; Onodugo OD
    Afr Health Sci; 2015 Sep; 15(3):941-8. PubMed ID: 26957985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.